ArticleAnnals of hematology2023

High susceptibility of febrile neutropenia in Japanese patients receiving venetoclax plus azacitidine therapy for acute myeloid leukemia.

Kensuke Matsuda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.